Troy A. Ignelzi
Director · Contineum Therapeutics, Inc.
Individual
- 2026
- Jun 26, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Troy A. Ignelzi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Third Rock Ventures V, L.P. - $34.39M in RAPP purchases and sales in the last 12 months
- Abraham Ceesay - $5.93M in RAPP purchases and sales in the last 12 months
- Krishnaswamy Yeleswaram - $4.46M in RAPP purchases and sales in the last 12 months
- Kumar Budur - $3.11M in HRMY purchases and sales in the last 12 months
- Cheryl Gault - $1.24M in RAPP purchases and sales in the last 12 months
- David Bredt - $1.14M in RAPP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Troy A. Ignelzi?
Troy A. Ignelzi is a corporate insider, tracked as Director of Contineum Therapeutics, Inc. (CTNM). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Troy A. Ignelzi last file a Form 4?
The most recent primary Form 4 on record is dated 26 June 2026, one of 3 filings going back to 2026.
